• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human V-set and transmembrane domain-containing protein 1 (VSTM1), Truncated

ACP08212

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP08212 Target NameVSTM1
Target SynonymsVSTM1; UNQ3033/PRO9835; V-set and transmembrane domain-containing protein 1; Signal inhibitory receptor on leukocytes-1; SIRL-1FormLyophilized powder
Expression SystemCustom Production. Please inquire and provide the desire expression system.Protein LengthPartial
Purity>85% (SDS-PAGE)Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDQ6UX27
Background Information
  • Uniprot Id

    Q6UX27

  • Target Species

    Human

  • Target Name

    VSTM1

  • Target Full Name

    V-set and transmembrane domain-containing protein 1

  • Target Function

    Behaves as a cytokine, promoting IL17A secretion by CD4+ T-cells, and differentiation and activation of IL17 producing helper T-cells (TH17).; Inhibitory immune receptor involved in the regulation of phagocytes.

  • Target Subcellular Location

    [Isoform 1]: Membrane; Single-pass membrane protein.; [Isoform 2]: Secreted.

  • Target Tissue Specificity

    Expressed on myeloid (neutrophils, eosinophils and monocytes) but not on lymphoid cells.

  • Target Synonyms

    VSTM1; UNQ3033/PRO9835; V-set and transmembrane domain-containing protein 1; Signal inhibitory receptor on leukocytes-1; SIRL-1

Inquire Recombinant Human V-set and transmembrane domain-containing protein 1 (VSTM1), Truncated Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification